a new hiv treatment pioneered using an antibody to attack the virus could lead to a new vaccine to prevent the infection
the first results to emerge from patient trials reveal the experimental therapy can dramatically reduce the level of virus in a patient 's blood - their viral load
scientists at the rockefeller university in new york believe a new antibody therapy could pave the way for an hiv vaccine after clinical trials revealed the treatment resulted in a 300-fold decrease in the amount of hiv , pictured , in sufferers ' blood in a person infected with hiv , there is an ongoing battle between the virus and the body 's immune system